In our HGSC cell cultures and ex vivo models, pharmacological RSK inhibition blocked the activation of the tumor‐promoting EphA2 activity, which in turn led to enhanced canonical tumor‐suppressive EphA2‐pY588 signaling, coincidentally sensitizing the cells to platinum‐induced apoptosis. The gene discussed is EPHA2; the disease is neoplasm.